- 1(current)
Q. No.Match the following columns and select the correct option.
| Column-I | Column-II | ||
| a. | Bt cotton | (i) | Gene therapy |
| b. | Adenosine deaminase deficiency | (ii) | Cellular defense |
| c. | RNAi | (iii) | Detection of HIV infection |
| d. | PCR | (iv) | Bacillus thuringiensis |
| a | b | c | d | |
| 1. | (iii) | (ii) | (i) | (iv) |
| 2. | (ii) | (iii) | (iv) | (i) |
| 3. | (i) | (ii) | (iii) | (iv) |
| 4. | (iv) | (i) | (ii) | (iii) |
Subtopic: Â Bt Crops |Â Interference RNA Tech |Â Gene Therapy |Â Molecular Diagnosis |
 94%
Level 1: 80%+
NEET - 2020
Hints
| Assertion(A): | Functional ADA cDNA genes must be inserted in the lymphocytes at the early embryonic stage to treat SCID. |
| Reason(R): | Cells in the embryonic stage are mortal, differentiated and easy to manipulate. |
| 1. | Both (A) and (R) are true and (R) is the correct explanation of (A). |
| 2. | Both (A) and (R) are true and (R) is not the correct explanation of (A). |
| 3. | (A) is true but (R) is false. |
| 4. | (A) is False but (R) is true. |
Subtopic: Â Gene Therapy |
Level 3: 35%-60%
Hints
Unlock IMPORTANT QUESTION
This question was bookmarked by 5 NEET 2025 toppers during their NEETprep journey. Get Target Batch to see this question.
✨ Perfect for quick revision & accuracy boost
Buy Target Batch
Access all premium questions instantly
Read the following statements:
How many of the above statements are correct?
1. Three
2. Four
3. Two
4. One
| (i) | Hybridoma is a cell produced by the fusion of two cells of different origin |
| (ii) | ADA deficiency can be cured by bone marrow transplantation which is a permanent cure |
| (iii) | All genetically modified organisms (GMO) are transgenic organisms |
| (iv) | IFN belong to a group of glycoprotein called cytokines |
| (v) | Pseudomonas putida can degrade toluene, camphor, octance and xylene |
How many of the above statements are correct?
1. Three
2. Four
3. Two
4. One
Subtopic: Â Gene Therapy |
Level 3: 35%-60%
Sorry!! currently, the explanation for the question is not provided. If you need further help, please email at support@neetprep.com with subject: Explanation Missing for Question Id: 362358
Hints
Sorry!! currently, the explanation for the question is not provided. If you need further help, please email at support@neetprep.com with subject: Explanation Missing for Question Id: 362358
Unlock IMPORTANT QUESTION
This question was bookmarked by 5 NEET 2025 toppers during their NEETprep journey. Get Target Batch to see this question.
✨ Perfect for quick revision & accuracy boost
Buy Target Batch
Access all premium questions instantly
Find the true (T)/false (F) statements and choose the correct option.
I. GMO may lead to health risk in humans
II. Interferons were discovered by Issacs and Lindenmann
III. Interferons can cure AIDS
IV. Antibodies derived from a single clone of cells which recognize only one kind of antigen, are called monoclonal antiobodies
I. GMO may lead to health risk in humans
II. Interferons were discovered by Issacs and Lindenmann
III. Interferons can cure AIDS
IV. Antibodies derived from a single clone of cells which recognize only one kind of antigen, are called monoclonal antiobodies
| I | II | III | IV | |
| 1. | T | T | F | T |
| 2. | T | T | T | T |
| 3. | F | T | T | T |
| 4. | T | F | F | T |
Subtopic: Â Gene Therapy |Â Transgenic Microbes & Animals |
Level 3: 35%-60%
Hints
Match List - I with List - II
Choose the correct answer from the options given below:
| List-I | List-II | ||
| (A) | Gene therapy | (I) | Separation of DNA fragments |
| (B) | RNA interference | (II) | Diagnostic test for AIDS |
| (C) | ELISA | (III) | Cellular defense |
| (D) | Gel Electrophoresis | (IV) | Allows correction of a gene defect |
Choose the correct answer from the options given below:
| Options: | (A) | (B) | (C) | (D) |
| 1. | IV | I | II | III |
| 2. | IV | II | III | I |
| 3. | IV | III | II | I |
| 4. | IV | III | I | II |
Subtopic: Â Interference RNA Tech |Â Med Applications & Humulin |Â Gene Therapy |Â Molecular Diagnosis |
 91%
Level 1: 80%+
NEET - 2023
Hints
- 1(current)
Q. No.
© 2025 GoodEd Technologies Pvt. Ltd.